| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.502 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.502 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.502 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
0.502 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.502 |
Evidence |
|
| CDH5 |
CDH5: Cadherin-5 precursor |
CTNND2 |
CTNND2, NPRAP: Catenin delta-2 |
0.502 |
Evidence |
|
| ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
RDX |
RDX: Radixin |
0.502 |
Evidence |
|
| DSG3 |
DSG3: Desmoglein-3 precursor |
CTNND2 |
CTNND2, NPRAP: Catenin delta-2 |
0.502 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
0.502 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
0.502 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
0.502 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.502 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.502 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
BMX |
IPI00514142 |
0.502 |
Evidence |
|
| MSN |
MSN: Moesin |
ICAM5 |
ICAM5, TLCN, TLN: Intercellular adhesion molecule 5 precursor |
0.502 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.502 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.502 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.502 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.502 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.502 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.502 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.502 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.502 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.502 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.502 |
Evidence |
|